Allison Jeynes-Ellis
Director/Board Member at AGENUS INC.
Net worth: 27 456 $ as of 2024-04-29
Network origin in Allison Jeynes-Ellis first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
31
| Public Company | Biotechnology | 31 |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.
8
| Holding Company | Biotechnology | 8 |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA.
4
| Holding Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Allison Jeynes-Ellis via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Soros Fund Management LLC
 Soros Fund Management LLC Investment ManagersFinance Soros Fund Management LLC (SFM) is a privately-held investment management firm now structured as a family office, but which was once a hedge fund manager. The firm was founded in 1969 and is headquartered in New York City. SFM serves as principal investment adviser to a group of funds managed for the benefit of Soros family cl fsients. | Investment Managers | Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree Doctorate Degree | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
| The University of Alabama | College/University | Undergraduate Degree Doctorate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| University of Maryland | College/University | Graduate Degree Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Gensia Sicor Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Spearhead Investments (Bio) Ltd. | Chairman | ||
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology cCAM Biotherapeutics Ltd. is a preclinical-stage company engaging in the development of immunotherapies to treat cancer. The company was founded by Silvia Noiman and Gal Markel in 2010 and is headquartered in Hod Ha'Sharon, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Vencor Capital (Pty ) Ltd. | Founder | ||
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Director of Finance/CFO Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Pontifax (Cayman) III LP | Investment Managers | Director/Board Member | |
| Pontifax (Israel) III LP | Investment Managers | Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science. | Investment Managers | Chairman Director of Finance/CFO | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal | ||
| MINK THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Treasurer Director/Board Member Investor Relations Contact Chief Executive Officer | |
| Seneb Biosciences, Inc. | Chief Executive Officer | ||
Kg Biopharma Consulting LLC
 Kg Biopharma Consulting LLC Miscellaneous Commercial ServicesCommercial Services Kg Biopharma Consulting LLC provides strategic advisory services. The private company is based in Wilton, CT. | Miscellaneous Commercial Services | President | |
Syncona Discovery Ltd.
 Syncona Discovery Ltd. Financial ConglomeratesFinance Part of Syncona Ltd., Syncona Discovery Ltd. is a British company that provides investment services. The company is based in London, UK. Syncona Discovery was founded in 2013. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Bond 2 Development 2 Gp Ltd. | Director/Board Member Director/Board Member | ||
| ROYALTY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AgenTus Therapeutics SA | Director/Board Member Chief Executive Officer |
Statistics
International
| United States | 28 |
| United Kingdom | 13 |
| Israel | 7 |
| Denmark | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Finance | 10 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 274 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 59 |
| Chairman | 54 |
| Undergraduate Degree | 42 |
Most connected contacts
| Insiders | |
|---|---|
| Samir Kaul | 56 |
| Ran Nussbaum | 38 |
| Martin Murphy | 33 |
| Ted Love | 31 |
| Kurt C. Wheeler | 28 |
| John Bradshaw | 27 |
| Ulf Arne Wiinberg | 26 |
| Anders Gersel Pedersen | 24 |
| David Chiswell | 23 |
| Gary Phillips | 20 |
| Timothy Wright | 20 |
| Genghis Lloyd-Harris | 19 |
| Paul Clark | 19 |
| Garo Armen | 17 |
| Kathryn Gregory | 16 |
- Stock Market
- Insiders
- Allison Jeynes-Ellis
- Company connections
